Health and wellness products company USANA Health Sciences (NYSE: USNA) will be announcing earnings results tomorrow afternoon. Here’s what to expect.
USANA beat analysts’ revenue expectations by 2.3% last quarter, reporting revenues of $213.6 million, down 3.4% year on year. It was a very strong quarter for the company, with an impressive beat of analysts’ EBITDA estimates and a solid beat of analysts’ EPS estimates.
Is USANA a buy or sell going into earnings? Read our full analysis here, it’s free.
This quarter, analysts are expecting USANA’s revenue to grow 6.7% year on year to $243 million, a reversal from the 8.3% decrease it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.70 per share.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. USANA has missed Wall Street’s revenue estimates three times over the last two years.
Looking at USANA’s peers in the consumer staples segment, some have already reported their Q1 results, giving us a hint as to what we can expect. Lamb Weston delivered year-on-year revenue growth of 4.3%, beating analysts’ expectations by 2.4%, and Simply Good Foods reported revenues up 15.2%, topping estimates by 1.6%. Lamb Weston traded up 9.1% following the results while Simply Good Foods was also up 9.2%.
Read our full analysis of Lamb Weston’s results here and Simply Good Foods’s results here.
When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we’ve found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback.
